Clinical Sciences, Stellenbosch University, Stellenbosch, South Africa
Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Thorax. 2024 Jun 14;79(7):676-679. doi: 10.1136/thorax-2023-221349.
Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022-2023. Medicines for symptomatic relief were widely available and affordable, while preventative treatments varied widely in cost, were less available and largely unaffordable. There is an urgent need to address these issues if the Sustainable Development Goal 3 is to be achieved for people with asthma by 2030.
目前缺乏有关低收入和中等收入国家（LMICs）慢性呼吸道疾病（CRD）基本药物的可获得性、成本和可负担性的最新数据，尽管大多数 CRD 患者生活在 LMICs 中。2022-2023 年，从 60 个 LMIC 收集了药店、医疗机构和中央药店中七种 CRD 药物的横断面数据。对症缓解药物广泛可得且负担得起，而预防治疗的成本差异很大，供应情况较差且大多无法负担。如果要在 2030 年实现哮喘患者的可持续发展目标 3，就迫切需要解决这些问题。
